- $239.75m
- $246.61m
- €38.18m
- 44
- 73
- 54
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41 | 7.76 | 85.6 | 26.6 | 38.2 |
Cost of Revenue | |||||
Gross Profit | 38.8 | 5.68 | 84.1 | 24.4 | 36 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 98.8 | 90.7 | 18.2 | 53.9 | 64.8 |
Operating Profit | -57.8 | -82.9 | 67.4 | -27.3 | -26.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -65.7 | -102 | 69.5 | -23.8 | -28.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -65.1 | -101 | 67.3 | -23.7 | -28.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -65.1 | -101 | 67.3 | -23.7 | -28.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -65.1 | -101 | 67.3 | -23.7 | -28.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.76 | -2.51 | 0.598 | -0.478 | -0.582 |
Dividends per Share |